TMBIM4 and Parkinson disease: The neuroprotective effects of pridopidine are also evident in models of Parkinson and Alzheimer diseases22,27 These effects are definitely S1R mediated because either pharmacological inhibition of the S1R or genetic deletion of the S1R gene completely abolish pridopidine’s protective effects.